Objectives of the Study
The main goals of our diabetes clinical trials are:
- Efficient Evaluation: Test how well GLP-1 receptor agonists lower HbA1c levels and improve blood sugar control in people with Type 2 diabetes.
- Safety Monitoring: Check the safety of the new treatment, including any possible side effects or negative reactions.
- Patient-Centric Outcomes: Collect information on how patients feel about their quality of life and their satisfaction with diabetes management.
Eligibility Criteria
To join our diabetes clinical trials participants need to meet certain criteria. Such as:
Age:
Participants must usually be adults aged 18 or older.
Diagnosis:
They must have a confirmed diagnosis of Type 2 diabetes, with specific HbA1c levels as stated in the study guidelines.
Exclusion Criteria:
Some medical conditions, medications, or previous participation in other trials may prevent people from joining.
What to Expect from the Study
Participants in our diabetes clinical trials can look forward to:
- Screening Process: A detailed check to see if they qualify, including reviewing medical history and lab tests.
- Treatment Administration: Receive the new GLP-1 receptor agonist therapy and have regular follow-up visits to track progress and health.
- Ongoing Support: Our team provides ongoing help, including information on managing diabetes and lifestyle changes.
Compensation: Possible payment for time and travel related to study visits.
Frequently Asked Questions
What do your diabetes clinical trials focus on?
Our diabetes clinical trials focus on Type 2 diabetes treatments using GLP-1 receptor agonists. Our goal is to find new therapies that can enhance the quality of life for people living with diabetes.
What is Type 2 diabetes?
Type 2 diabetes is a long-term condition in which the body does not use insulin properly, resulting in high blood sugar levels. It can lead to serious health problems such as heart disease, kidney failure, and vision loss, so managing it well is critical.
What are the objectives of the study?
The study aims to test how well GLP-1 receptor agonists lower HbA1c levels and improve blood sugar control, monitor the safety of the new treatment and any side effects, and collect information on patients’ quality of life and satisfaction with their diabetes management.
Who is eligible to join?
Participants must usually be adults aged 18 or older with a confirmed diagnosis of Type 2 diabetes and specific HbA1c levels as defined by the study. Certain medical conditions, medications, or prior participation in other trials may prevent someone from joining.
Volunteer Reviews
Google Based Reviews
A’m very grateful about this opportunity the staff are very professional and friendly I recommend AGA Clínica Research because they really help people to improve their lives thanks
~ Gladys Alvarez
I am very happy with the attention first of the doctor who is an excellent doctor, very kind, an excellent human being and the attention of his assistants such as the laboratory assistant..
~ Rosario Casais
Amazing service! The staff is very nice and patient with me and my family. I was seen right away. No wait time. Great experience!
~ Erika
Employees are very professional and friendly. Always able to convey the necessary information to the patient in the most accessible way.
~ Paola Allende
Very detailed and thorough in explaining. The office staff is friendly, warm and attentive.
~ Milerka Lantigua
Excellent service from the staff, the phlebotomist is very experienced and very good. The atmosphere is very pleasant and the coordinators are girls who are very attentive to everyone. The long time doctor is still here.
~ Dignora Ortega
Join the Battle Against Diabetes
Our diabetes clinical trials offer a chance to improve treatments for people with Type 2 diabetes. Joining us at AGA Clinical Trials means contributing to new therapies and better health for patients everywhere. Dial (786) 326-1583 for more information.